Searched for
NUTRACEUTICAL MANUFACTURER VATAVE HEALTHCARE
FSSAI cracks down on two firms over misleading product claims; halts sale of Folineuro Syrup, Neuherbs True VitaminIndia's food regulator FSSAI has restricted Vatave Healthcare from selling its Folineuro syrup. The company made misleading claims about im...- Arboreal Bioinnovations raises Rs 230 crore led by Edelweiss’s EAAA, OmnivoreSpecialty food ingredient startup Arboreal Bioinnovations has raised Rs 230 crore in a Series A funding round. This capital will fuel manuf...
- ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- Cupid increases investment by $5 million in GII’s Healthcare-focused platformCupid Ltd has made an additional $5 million investment in GII’s healthcare-focused investment platform, funded through internal accruals. T...
- FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plantThe FSSAI has suspended Dior Pharmaceuticals' license due to serious violations. The nutraceutical factory operated with severely deficient...
- Motilal Oswal raises mid and smallcap allocation to 50%, stays neutral on Indian equitiesMotilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...
- Edelweiss Alternatives raises over Rs 1,200 crore for second Discovery fund; backs Arboreal BioEdelweiss Alternatives Asset Advisors has secured over Rs 1,200 crore for its second Discovery Fund and made its first investment by leadin...
- Centre readies healthcare compliance overhaul to boost hospitals in tier-2, tier-3 citiesIndia plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The govt will ...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- FSSAI suspends licence of Westend Agro Products for altering expiry dates, other violationsThe food regulator FSSAI suspended Westend Agro Products' license due to serious violations. Inspection revealed altered manufacturing and ...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- FSSAI penalises Sopan Restaurant for sub-standard pantry car food on Chandigarh-Dibrugarh ExpressThe FSSAI has penalised Sopan Restaurant for selling sub-standard food. This action followed an analysis of milk samples from a train pantr...
- Bain Capital acquires Vitabiotics: UK nutraceutical giant with India’s Meyer Organics valued at $850-900 millionPrivate equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...
- Cabinet approves Rs 3,030 crore Bhavya Rasayan Scheme for three chemical parksWith a financial commitment of Rs 3,030 crore, the Union Cabinet has approved the Bhavya Rasayan Scheme. This forward-thinking initiative w...
- FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unitThe FSSAI has suspended Rehaan Healthcare's license after finding serious rule violations. The company's manufacturing unit was found in an...
- Bain Capital to accquire UK's leading vitamin company VitabioticsPrivate equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...
- FSSAI suspends Rehaan Healthcare licence over serious food safety violationsFSSAI has suspended Rehaan Healthcare’s licence after inspections revealed serious violations at its health supplements and nutraceutical m...
- LetterOne taps Rahul Mukim to spearhead $2 billion India pushLuxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...
Load More
